Psoriasis is an autoimmune disease that affects over 125 million people worldwide, that is up to 3% of the total population! At AnTolRx, our targeted approach actively promotes immune tolerance by inducing an anti-inflammatory phenotype and thus better treat disease. We are actively developing a potential therapy for psoriasis! Let’s get connected and make everyone aware on World Psoriasis Day!
- Join us at the 3rd Antigen-Specific Immune Tolerance Summit (ASIT)! January 20, 2020
- Meet us at the J.P. Morgan Healthcare Conference 2020! December 4, 2019
One Kendall Square
Building 1400 West, Suite 14303
Cambridge, MA 02139